Overview
Conference: March 12-13, 2024
DIA’s Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices. Join thought leaders from industry, legal, public affairs, and government for interactive and compelling discussions that will shape policy and define strategic priorities within the advertising and promotion regulatory space.
This conference is geared towards both early and late-career professionals with content that advances the understanding of current regulatory policies, details the latest strategies for professional development, and discusses the trends in advertising for medical products. You will have the opportunity to network with key thought leaders from the FDA, industry, and other regulatory agencies, while simultaneously discussing the challenges and opportunities of marketing pharmaceuticals and medical devices today.
While we develop our 2024 agenda, please take a moment to review the 2023 final agenda.
Featured
Who should attend?
-
Meeting Designed For
Join professionals from every corner of the vast realm of Advertising and Promotion Regulatory Affairs:
- Regulatory Affairs
- Marketing
- Communications
- Compliance
- Medical Information and Affairs
- Legal
- Patient Engagement
Program Committee
-
Alyson Andrikanich, PharmD • Senior Director, Advertising and Promotion, Regulatory Affairs Americas
Bayer Pharmaceuticals, United States -
Lynn Bowen, PhD • Vice President, Regulatory Affairs Advertising Promotion & Labeling
Alkermes, Inc., United States -
Bob Dean, MBA • Head of Global Labeling Strategy & Ad/Promo
EMD Serono, United States -
Anthony Genovese • Group Leader, Regulatory Advertising and Promotion
Johnson and Johnson, United States -
Nicol Lorraine George, PharmD, RPh • Vice President, Promotional & Labeling Services
ProPharma Group, United States -
Catherine Gray, PharmD • Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States -
Joanne Hawana, JD, MS • Member
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States -
Georgina Lee, PharmD • Executive Director, Regulatory Advertising and Promotion
Sage Therapeutics, United States -
Amy Muhlberg, PhD • Deputy Director, OPDP’s Division of Promotion Policy, Research and Operations
FDA, United States -
Moulakshi Roychowdhury, JD, PharmD • Global Head, Regulatory Affairs, Advertising & Promotion, Allergan Aesthetics
AbbVie, United States -
Dale Cooke, JD, MA • President
PhillyCooke Consulting , United States -
Mark Gaydos • Vice President & Global Head, Advertising, Promotion & Labeling
Sanofi, United States -
Micheline Awad, MBA • Senior Director, Regulatory Affairs - Advertising, Promotions, and Labeling
Turning Point Therapeutics, Inc., A Bristol Myers Squibb Company, United States -
Representative Invited • DIA, United States
Contact us
Registration Questions?
Additional Information
Discover DIA’s Live In-Person EventsCONTENT PREVIEW WEBINAR
Responsive Search Ads (RSA) and Prescription Drug Promotion
